MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Clopidogrel

Clopidogrel 75mg tablets

Compatible

Stability notes for Clopidogrel 75mg tablets

No special precautions for storage.

There are anecdotal reports of clopidogrel hydrochloride tablets becoming brittle and breaking after storage in MCA.

Provenance

This compatibility recommendation is derived from Plavix 75mg tablets (Sanofi) and Clopidogrel 75mg tablets (Accord Healthcare Ltd).

Suppliers (24) of Clopidogrel 75mg tablets
Clopidogrel 75mg tablets (A A H Pharmaceuticals Ltd)
Clopidogrel 75mg tablets (Accord-UK Ltd)
Clopidogrel 75mg tablets (Alliance Healthcare (Distribution) Ltd)
Clopidogrel 75mg tablets (Almus Pharmaceuticals Ltd)
Clopidogrel 75mg tablets (Aspire Pharma Ltd)
Clopidogrel 75mg tablets (Bristol Laboratories Ltd)
Clopidogrel 75mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Clopidogrel 75mg tablets (Kent Pharma (UK) Ltd)
Clopidogrel 75mg tablets (Krka UK Ltd)
Clopidogrel 75mg tablets (Macleods Pharma UK Ltd)
Clopidogrel 75mg tablets (Medihealth (Northern) Ltd)
Clopidogrel 75mg tablets (Medreich Plc)
Incompatible
Clopidogrel 75mg tablets (Milpharm Ltd)
Clopidogrel 75mg tablets (MSN Laboratories Europe Ltd)
Clopidogrel 75mg tablets (Noumed Life Sciences Ltd)
Clopidogrel 75mg tablets (Phoenix Healthcare Distribution Ltd)
Clopidogrel 75mg tablets (Relonchem Ltd)
Clopidogrel 75mg tablets (Torrent Pharma (UK) Ltd)
Clopidogrel 75mg tablets (Zentiva Pharma UK Ltd)
Plavix 75mg tablets (CST Pharma Ltd)
Plavix 75mg tablets (Ethigen Ltd)
Plavix 75mg tablets (Lexon (UK) Ltd)
Plavix 75mg tablets (Sanofi)
Plavix 75mg tablets (Sigma Pharmaceuticals Plc)

Clopidogrel 300mg tablets

No stability information

Stability notes for Clopidogrel 300mg tablets

There are no stability notes for this medicine.

Supplier

Plavix 300mg tablets (Sanofi)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.